Stanford (Calif.) Medicine researchers surveyed more than 1,000 people across the U.S. in August and December, presenting scenarios of varying vaccine efficacy, minor side effects and severe adverse reactions.
If vaccine efficacy is at least 70 percent, people are more likely to get vaccinated, the findings showed.
At the same time, minor side effects such as fever or a sore arm had little influence on respondents’ likelihood of getting vaccinated. Serious side effects including anaphylaxis or temporary paralysis swayed respondents toward not getting the vaccine if the chances of developing the reactions were relatively high, such as 1/100,000, but had little effect when the chances were 1/1 million or 1/100 million.
To view the full findings, click here.
More articles on public health:
Severely sick newborn with new COVID-19 variant had 51,418X higher viral load
COVID-19 hospitalizations by state: Feb. 24
J&J’s vaccine is safe, FDA says; California variant more contagious, early research shows — 7 COVID-19 updates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.